Clinical and Pathophysiological Description of Ocular Ischemic Syndrome
Sponsor
Glostrup University Hospital, Copenhagen (Other)
Overall Status
Completed
CT.gov ID
NCT00403195
Collaborator
Rigshospitalet, Denmark (Other), University Hospital, Gentofte, Copenhagen (Other)
13
1
26
0.5
Study Details
Study Description
Brief Summary
The purpose of this study is to characterize the disease Ocular Ischemic Syndrome.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The disease Ocular Ischemic Syndrome (OIS) is not a well described entity. It occurs after a long-standing period of extremely low blood supply to the retina caused by atherosclerosis of the carotid arteries. In this study we will analyze why OIS is developed in some patients and not developed in others. The patients with OIS will be thorough examined and will be compared with 1) a control group of healthy people and 2) with control group of patients with diabetic retinopathy. Furthermore the impact of vascular surgery on OIS will be analyzed.
Study Design
Study Type:
Observational
Actual Enrollment
:
13 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Pathophysiological Analysis of Ocular Ischemic Syndrome and the Response to Vascular Surgery
Study Start Date
:
Nov 1, 2006
Actual Primary Completion Date
:
Jan 1, 2009
Actual Study Completion Date
:
Jan 1, 2009
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Ocular ischemic syndrome
Exclusion Criteria:
- Any other active ocular disease
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Department of Ophthalmology, Glostrup Hospital, University of Copenhagen | Glostrup | Denmark | 2600 |
Sponsors and Collaborators
- Glostrup University Hospital, Copenhagen
- Rigshospitalet, Denmark
- University Hospital, Gentofte, Copenhagen
Investigators
- Study Director: Michael Larsen, Professor,
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Peter Kofoed,
Principal investigator,
Glostrup University Hospital, Copenhagen
ClinicalTrials.gov Identifier:
NCT00403195
Other Study ID Numbers:
- OIS
First Posted:
Nov 23, 2006
Last Update Posted:
Sep 10, 2012
Last Verified:
Sep 1, 2012
Keywords provided by Peter Kofoed,
Principal investigator,
Glostrup University Hospital, Copenhagen
Additional relevant MeSH terms: